210 related articles for article (PubMed ID: 30598509)
1. A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonists.
Patil R; Mohanty B; Liu B; Chandrashekaran IR; Headey SJ; Williams ML; Clements CS; Ilyichova O; Doak BC; Genissel P; Weaver RJ; Vuillard L; Halls ML; Porter CJH; Scanlon MJ
J Biol Chem; 2019 Mar; 294(10):3720-3734. PubMed ID: 30598509
[TBL] [Abstract][Full Text] [Related]
2. Fatty Acid-binding Proteins 1 and 2 Differentially Modulate the Activation of Peroxisome Proliferator-activated Receptor α in a Ligand-selective Manner.
Hughes ML; Liu B; Halls ML; Wagstaff KM; Patil R; Velkov T; Jans DA; Bunnett NW; Scanlon MJ; Porter CJ
J Biol Chem; 2015 May; 290(22):13895-906. PubMed ID: 25847235
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-α activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway.
Nakaya K; Tohyama J; Naik SU; Tanigawa H; MacPhee C; Billheimer JT; Rader DJ
Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1276-82. PubMed ID: 21441141
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor alpha agonists enhance cardiomyogenesis of mouse ES cells by utilization of a reactive oxygen species-dependent mechanism.
Sharifpanah F; Wartenberg M; Hannig M; Piper HM; Sauer H
Stem Cells; 2008 Jan; 26(1):64-71. PubMed ID: 17951219
[TBL] [Abstract][Full Text] [Related]
6. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
[TBL] [Abstract][Full Text] [Related]
7. C/EBP-β Is Differentially Affected by PPARα Agonists Fenofibric Acid and GW7647, But Does Not Change Apolipoprotein A-I Production During ER-Stress and Inflammation.
van der Krieken SE; Popeijus HE; Konings M; Dullens SP; Mensink RP; Plat J
J Cell Biochem; 2017 Apr; 118(4):754-763. PubMed ID: 27618583
[TBL] [Abstract][Full Text] [Related]
8. Transcription of genes involved in fat metabolism in chicken embryos exposed to the peroxisome proliferator-activated receptor alpha (PPARα) agonist GW7647 or to perfluorooctane sulfonate (PFOS) or perfluorooctanoic acid (PFOA).
Strömqvist M; Olsson JA; Kärrman A; Brunström B
Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jun; 156(1):29-36. PubMed ID: 22465071
[TBL] [Abstract][Full Text] [Related]
9. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease.
Guzmán C; Benet M; Pisonero-Vaquero S; Moya M; García-Mediavilla MV; Martínez-Chantar ML; González-Gallego J; Castell JV; Sánchez-Campos S; Jover R
Biochim Biophys Acta; 2013 Apr; 1831(4):803-18. PubMed ID: 23318274
[TBL] [Abstract][Full Text] [Related]
10. Activation of peroxisome proliferator-activated receptor-α enhances fatty acid oxidation in human adipocytes.
Lee JY; Hashizaki H; Goto T; Sakamoto T; Takahashi N; Kawada T
Biochem Biophys Res Commun; 2011 Apr; 407(4):818-22. PubMed ID: 21443859
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells.
Muoio DM; Way JM; Tanner CJ; Winegar DA; Kliewer SA; Houmard JA; Kraus WE; Dohm GL
Diabetes; 2002 Apr; 51(4):901-9. PubMed ID: 11916905
[TBL] [Abstract][Full Text] [Related]
12. Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis.
Yan T; Luo Y; Yan N; Hamada K; Zhao N; Xia Y; Wang P; Zhao C; Qi D; Yang S; Sun L; Cai J; Wang Q; Jiang C; Gavrilova O; Krausz KW; Patel DP; Yu X; Wu X; Hao H; Liu W; Qu A; Gonzalez FJ
Hepatology; 2023 Jan; 77(1):239-255. PubMed ID: 35460276
[TBL] [Abstract][Full Text] [Related]
13. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.
Paukkeri EL; Leppänen T; Sareila O; Vuolteenaho K; Kankaanranta H; Moilanen E
Br J Pharmacol; 2007 Dec; 152(7):1081-91. PubMed ID: 17891158
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-alpha control of lipid and glucose metabolism in human white adipocytes.
Ribet C; Montastier E; Valle C; Bezaire V; Mazzucotelli A; Mairal A; Viguerie N; Langin D
Endocrinology; 2010 Jan; 151(1):123-33. PubMed ID: 19887568
[TBL] [Abstract][Full Text] [Related]
15. PPAR-α agonist regulates amyloid-β generation via inhibiting BACE-1 activity in human neuroblastoma SH-SY5Y cells transfected with APPswe gene.
Zhang H; Gao Y; Qiao PF; Zhao FL; Yan Y
Mol Cell Biochem; 2015 Oct; 408(1-2):37-46. PubMed ID: 26092426
[TBL] [Abstract][Full Text] [Related]
16. Human FABP1 T94A variant impacts fatty acid metabolism and PPAR-α activation in cultured human female hepatocytes.
McIntosh AL; Huang H; Storey SM; Landrock KK; Landrock D; Petrescu AD; Gupta S; Atshaves BP; Kier AB; Schroeder F
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G164-76. PubMed ID: 24875102
[TBL] [Abstract][Full Text] [Related]
17. Subfunctionalization of peroxisome proliferator response elements accounts for retention of duplicated fabp1 genes in zebrafish.
Laprairie RB; Denovan-Wright EM; Wright JM
BMC Evol Biol; 2016 Jul; 16(1):147. PubMed ID: 27421266
[TBL] [Abstract][Full Text] [Related]
18. Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis.
van der Meer DL; Degenhardt T; Väisänen S; de Groot PJ; Heinäniemi M; de Vries SC; Müller M; Carlberg C; Kersten S
Nucleic Acids Res; 2010 May; 38(9):2839-50. PubMed ID: 20110263
[TBL] [Abstract][Full Text] [Related]
19. Activating PPARα prevents post-ischemic contractile dysfunction in hypertrophied neonatal hearts.
Lam VH; Zhang L; Huqi A; Fukushima A; Tanner BA; Onay-Besikci A; Keung W; Kantor PF; Jaswal JS; Rebeyka IM; Lopaschuk GD
Circ Res; 2015 Jun; 117(1):41-51. PubMed ID: 25977309
[TBL] [Abstract][Full Text] [Related]
20. PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat.
Okishio S; Yamaguchi K; Ishiba H; Tochiki N; Yano K; Takahashi A; Kataoka S; Okuda K; Seko Y; Liu Y; Fujii H; Takahashi D; Ito Y; Kamon J; Umemura A; Moriguchi M; Yasui K; Okanoue T; Itoh Y
Sci Rep; 2020 Nov; 10(1):19578. PubMed ID: 33177546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
